Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study

I. Walraven, E. van 't Riet, C.D.A. Stehouwer, B.C.P. Polak, A.C. Moll, J.M. Dekker, G. Nijpels

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1148-1154
JournalDiabetologia
Volume56
Issue number5
DOIs
Publication statusPublished - 2013

Cite this

@article{a1ce47f5045f461e8452e8995edb6b78,
title = "Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study",
author = "I. Walraven and {van 't Riet}, E. and C.D.A. Stehouwer and B.C.P. Polak and A.C. Moll and J.M. Dekker and G. Nijpels",
year = "2013",
doi = "10.1007/s00125-013-2864-6",
language = "Undefined/Unknown",
volume = "56",
pages = "1148--1154",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "5",

}

Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study. / Walraven, I.; van 't Riet, E.; Stehouwer, C.D.A.; Polak, B.C.P.; Moll, A.C.; Dekker, J.M.; Nijpels, G.

In: Diabetologia, Vol. 56, No. 5, 2013, p. 1148-1154.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Fasting proinsulin levels are significantly associated with 20 year cancer mortality rates. The Hoorn Study

AU - Walraven, I.

AU - van 't Riet, E.

AU - Stehouwer, C.D.A.

AU - Polak, B.C.P.

AU - Moll, A.C.

AU - Dekker, J.M.

AU - Nijpels, G.

PY - 2013

Y1 - 2013

U2 - 10.1007/s00125-013-2864-6

DO - 10.1007/s00125-013-2864-6

M3 - Article

VL - 56

SP - 1148

EP - 1154

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 5

ER -